These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17566478)

  • 21. Zonisamide concentrations during pregnancy.
    Oles KS; Bell WL
    Ann Pharmacother; 2008 Jul; 42(7):1139-41. PubMed ID: 18577760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacosamide treatment of juvenile myoclonic epilepsy.
    Afra P; Adamolekun B
    Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of zonisamide in pediatric patients.
    Santos CC; Brotherton T
    Pediatr Neurol; 2005 Jul; 33(1):12-4. PubMed ID: 15876518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study.
    Vossler DG; Conry JA; Murphy JV;
    Epileptic Disord; 2008 Mar; 10(1):31-4. PubMed ID: 18367429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review.
    Tan HJ; Martland TR; Appleton RE; Kneen R
    Seizure; 2010 Jan; 19(1):31-5. PubMed ID: 19942456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zonisamide prophylaxis in refractory pediatric headache.
    Pakalnis A; Kring D
    Headache; 2006 May; 46(5):804-7. PubMed ID: 16643584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction to zonisamide.
    Baulac M
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonisamide: physician and patient experiences.
    Marmarou A; Pellock JM
    Epilepsy Res; 2005; 64(1-2):63-9. PubMed ID: 15869867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy.
    You SJ; Jung DE; Kim HD; Lee HS; Kang HC
    Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
    You SJ; Kang HC; Kim HD; Lee HS; Ko TS
    Brain Dev; 2008 Apr; 30(4):287-90. PubMed ID: 17959327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of juvenile myoclonic epilepsy.
    Verrotti A; Manco R; di Marco G; Chiarelli F; Franzoni E
    Expert Rev Neurother; 2006 Jun; 6(6):847-54. PubMed ID: 16784408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of Japanese experience-controlled and uncontrolled trials.
    Yagi K
    Seizure; 2004 Dec; 13 Suppl 1():S11-5; discussion S16. PubMed ID: 15511680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management and monitoring of patients treated with zonisamide: the OZONE study.
    Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B
    Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.
    Kelemen A; Rásonyl G; Neuwirth M; Barcs G; Szucs A; Jakus R; Fabó D; Juhos V; Pálfy B; Halász P
    Ideggyogy Sz; 2011 Mar; 64(5-6):187-92. PubMed ID: 21688720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of zonisamide: our experience.
    Yamauchi T; Aikawa H
    Seizure; 2004 Dec; 13 Suppl 1():S41-8; discussion S49. PubMed ID: 15511689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.